- Home
- PFL vs LAB Comparison
PFL vs LAB Comparison
Compare PFL & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PFL | LAB |
|---|---|---|
| Founded | 2003 | 1999 |
| Country | United States | United States |
| Employees | N/A | 389 |
| Industry | Finance Companies | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 395.7M | 394.3M |
| IPO Year | 2003 | 2008 |
Fundamental Metrics
Financial Performance| Metric | PFL | LAB |
|---|---|---|
| Price | $7.73 | $0.99 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $1.35 |
| AVG Volume (30 Days) | 167.6K | ★ 2.3M |
| Earning Date | 01-01-0001 | 05-05-2026 |
| Dividend Yield | ★ 11.53% | N/A |
| EPS Growth | N/A | ★ 61.54 |
| EPS | N/A | ★ 0.33 |
| Revenue | N/A | ★ $101,937,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.63 |
| P/E Ratio | ★ N/A | $3.05 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.60 | $0.87 |
| 52 Week High | $8.70 | $1.72 |
Technical Indicators
Market Signals| Indicator | PFL | LAB |
|---|---|---|
| Relative Strength Index (RSI) | 26.02 | 55.24 |
| Support Level | $7.60 | $0.92 |
| Resistance Level | $8.50 | $1.02 |
| Average True Range (ATR) | 0.06 | 0.05 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 1.32 | 73.27 |
Price Performance
Historical ComparisonAbout PFL PIMCO Income Strategy Fund Shares of Beneficial Interest
PIMCO Income Strategy Fund is a United States-based closed-end management investment company. The fund's investment objective is to seek high current income, consistent with the preservation of capital. The company seeks to achieve its objectives by investing in a diversified portfolio of floating and fixed-rate debt instruments.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.